The label’s names for bloating and gas
The US tables use two clinical terms. Abdominal distension is the feeling, or visible sign, of a swollen belly; flatulence is passing more gas than usual. The Medication Guide turns them back into “feeling bloated” and “gas”. Both appear in the adult 2.4 mg pool of three placebo-controlled studies of up to 68 weeks (2,116 people on the medicine, 1,261 on placebo); only flatulence reached the table for the 7.2 mg trials. [1]
| Reaction, source and pool | Placebo | 2.4 mg | 7.2 mg |
|---|---|---|---|
| Abdominal distension, US Table 3, adults [1] | 5% | 7% | — |
| Flatulence, US Table 3, adults [1] | 4% | 6% | — |
| Flatulence, US Table 4, 7.2 mg trials [1] | 2% | 2% | 4% |
| Abdominal distension, Canadian Table 4 [3] | 5.1% | 7.0% | — |
| Flatulence, Canadian Table 4 [3] | 4.2% | 5.9% | — |
| Both, EU SmPC 4.8 [2] | not given | “common” | — |
Small gaps over a busy placebo column
For bloating, 7% on Wegovy® compares with 5% on placebo; for gas, 6% against 4%. In the same pool, nausea was 44% against 16%. [1] A fair amount of the bloating and gas in these trials happened without the medicine, and the extra share in the treatment arm was modest.
Everyone in the trials, on medicine or placebo, was asked to follow a reduced-calorie diet and increase activity (section 14.2), so changes in what people ate apply to both columns. [1] A pooled analysis of STEP 1–3 found that 98.1% of digestive events on semaglutide 2.4 mg were mild to moderate and most occurred during or shortly after dose escalation. [4]
The higher dose and teenagers
The 7.2 mg trials randomised 1,311 people to 7.2 mg, 304 to 2.4 mg and 303 to placebo for 72 weeks. Flatulence was 2% on placebo and 2% on 2.4 mg, then 4% on 7.2 mg. Abdominal distension does not appear in that table, which only includes reactions more frequent on 7.2 mg than on both other arms, so there is no bloating figure for 7.2 mg. Section 2.2 describes 7.2 mg as an option only after at least four weeks on 2.4 mg. [1]
The adolescent table starts at 3% and lists neither term, but the text of section 6.1 names flatulence among digestive reactions more frequent on Wegovy® than on placebo in that trial. [1]
Why bloating may happen: three layers
- What the label supports: bloating and gas belong to a cluster of digestive reactions that were more frequent on the injection and concentrated around dose increases, and semaglutide delays stomach emptying (section 12.2). [1] The label does not say slower emptying causes bloating.
- Shown in the data: neither reaction rose clearly with dose, apart from flatulence at 7.2 mg (4% versus 2%). [1]
- General background, not shown for Wegovy®: NIH explains that gas forms when swallowed air enters the gut and when bacteria in the large intestine break down carbohydrates that the stomach and small intestine did not fully digest. [5] NIH also notes that only about half of people who feel bloated have a belly that is actually larger than usual. [5]
Gut conditions that cause the same feeling
NIH lists several conditions that can increase gas or bloating: irritable bowel syndrome and other disorders of how the gut and brain work together, lactose or fructose intolerance, small intestinal bacterial overgrowth, coeliac disease, constipation, reflux disease and gastroparesis. Rarely, a blockage of the digestive tract, including from bowel, ovarian or stomach cancer, is the cause. [5]
Constipation is the one most likely to overlap on Wegovy®: it was reported by 24% of adults on 2.4 mg, against 11% on placebo. [1] Section 6.2 also lists ileus and intestinal obstruction among post-approval reports for semaglutide, without a rate. [1]
Food, drink and other steps NIH describes
To reduce gas symptoms, NIH says a doctor may suggest smaller, more frequent meals and eating less of the foods that bother you. Foods it links with more gas include cruciferous vegetables such as broccoli, cauliflower and kale, beans, peas and lentils, foods high in fibre, fructose or lactose, and sugar-free sweets or gum with sweeteners ending in “-ol”. [6] It adds that a doctor may suggest over-the-counter products depending on your symptoms, and asks you to talk with a doctor before using supplements or probiotics. [6]
The Wegovy® label has no bloating-specific advice. It asks you to tell your provider about every over-the-counter medicine and supplement because Wegovy® slows stomach emptying, [1] and Novo Nordisk’s patient page lists feeling bloated and gas among the common side effects to talk over with your healthcare professional. [8]
Wegovy® is a registered trademark of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| Severe stomach pain that does not ease, sometimes reaching the back, with or without vomiting | Stop Wegovy® and call your provider right away | Emergency | Medication Guide [1] |
| Sudden, sharp belly pain, a rigid or tender belly, or being unable to pass stool while vomiting | Emergency number or emergency room | Emergency | MedlinePlus [7] |
| Bloating with severe constipation, vomiting or a belly that keeps swelling | Your prescriber the same day | Today | Wegovy® section 6.2 [1]; MedlinePlus [7] |
| Bloating that lasts more than 2 days | Your provider | Today | MedlinePlus [7] |
| Gas or bloating that changes suddenly, bothers you, or comes with weight loss, diarrhoea or pain | Your doctor at an appointment | At your next appointment | NIDDK [5] |
